B

Bonus Biogroup Ltd
TASE:BONS

Watchlist Manager
Bonus Biogroup Ltd
TASE:BONS
Watchlist
Price: 11.4 ILS 15.15% Market Closed
Market Cap: 139.4m ILS
Have any thoughts about
Bonus Biogroup Ltd?
Write Note

Bonus Biogroup Ltd
Investor Relations

Bonus Biogroup Ltd. is a biotechnology company engaging in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Joseph Rauch M.B.A.
Executive Chairman of the Board
No Bio Available
Dr. Shai Meretzki Ph.D.
Founder, CEO, President & Director
No Bio Available
Mr. Yoni Livne CPA
Chief Financial Officer
No Bio Available
Dr. Dror Ben David Ph.D.
Chief Operations Officer
No Bio Available
Dr. Vered Kivity M.B.A., Ph.D.
Head of Regulatory Affairs & VP of Clinical Affairs
No Bio Available

Contacts

Address
Haifa
Matam
Contacts
+972732067100.0
www.bonusbiogroup.com